Annual Cash & Cash Equivalents
$482.37 M
-$591.66 M-55.09%
December 31, 2023
Summary
- As of February 7, 2025, INSM annual cash & cash equivalents is $482.37 million, with the most recent change of -$591.66 million (-55.09%) on December 31, 2023.
- During the last 3 years, INSM annual cash & cash equivalents has fallen by -$50.38 million (-9.46%).
- INSM annual cash & cash equivalents is now -55.09% below its all-time high of $1.07 billion, reached on December 31, 2022.
Performance
INSM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$461.45 M
-$785.35 M-62.99%
September 30, 2024
Summary
- As of February 7, 2025, INSM quarterly cash and cash equivalents is $461.45 million, with the most recent change of -$785.35 million (-62.99%) on September 30, 2024.
- Over the past year, INSM quarterly cash and cash equivalents has dropped by -$25.66 million (-5.27%).
- INSM quarterly cash and cash equivalents is now -62.99% below its all-time high of $1.25 billion, reached on June 30, 2024.
Performance
INSM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
INSM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.1% | -5.3% |
| 3 y3 years | -9.5% | -5.3% |
| 5 y5 years | -2.6% | -5.3% |
INSM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.1% | at low | -63.0% | +11.3% |
| 5 y | 5-year | -55.1% | at low | -63.0% | +12.6% |
| alltime | all time | -55.1% | >+9999.0% | -63.0% | >+9999.0% |
Insmed Incorporated Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $461.45 M(-63.0%) |
| Jun 2024 | - | $1.25 B(+109.3%) |
| Mar 2024 | - | $595.73 M(+23.5%) |
| Dec 2023 | $482.37 M(-55.1%) | $482.37 M(-1.0%) |
| Sep 2023 | - | $487.11 M(-20.5%) |
| Jun 2023 | - | $612.88 M(-36.7%) |
| Mar 2023 | - | $968.91 M(-9.8%) |
| Dec 2022 | $1.07 B(+49.8%) | $1.07 B(+159.0%) |
| Sep 2022 | - | $414.63 M(-0.3%) |
| Jun 2022 | - | $416.08 M(-19.3%) |
| Mar 2022 | - | $515.70 M(-28.1%) |
| Dec 2021 | $716.78 M(+34.5%) | $716.78 M(-15.3%) |
| Sep 2021 | - | $846.56 M(-8.8%) |
| Jun 2021 | - | $928.33 M(+126.6%) |
| Mar 2021 | - | $409.75 M(-23.1%) |
| Dec 2020 | $532.76 M(+9.3%) | $532.76 M(-9.5%) |
| Sep 2020 | - | $588.75 M(-8.3%) |
| Jun 2020 | - | $641.91 M(+49.6%) |
| Mar 2020 | - | $428.94 M(-12.0%) |
| Dec 2019 | $487.43 M(-1.5%) | $487.43 M(-9.0%) |
| Sep 2019 | - | $535.63 M(-10.9%) |
| Jun 2019 | - | $601.26 M(+43.1%) |
| Mar 2019 | - | $420.23 M(-15.1%) |
| Dec 2018 | $495.07 M(+29.9%) | $495.07 M(-12.8%) |
| Sep 2018 | - | $567.57 M(-10.5%) |
| Jun 2018 | - | $634.33 M(-7.6%) |
| Mar 2018 | - | $686.58 M(+80.1%) |
| Dec 2017 | $381.17 M(+134.4%) | $381.17 M(-11.5%) |
| Sep 2017 | - | $430.68 M(+372.9%) |
| Jun 2017 | - | $91.06 M(-27.6%) |
| Mar 2017 | - | $125.84 M(-22.6%) |
| Dec 2016 | $162.59 M(-42.5%) | $162.59 M(-18.9%) |
| Sep 2016 | - | $200.52 M(-10.1%) |
| Jun 2016 | - | $223.11 M(-11.8%) |
| Mar 2016 | - | $252.87 M(-10.6%) |
| Dec 2015 | $282.88 M(+77.7%) | $282.88 M(-9.0%) |
| Sep 2015 | - | $310.97 M(-7.2%) |
| Jun 2015 | - | $335.03 M(+149.0%) |
| Mar 2015 | - | $134.55 M(-15.5%) |
| Dec 2014 | $159.23 M(+39.8%) | $159.23 M(-4.8%) |
| Sep 2014 | - | $167.31 M(+102.3%) |
| Jun 2014 | - | $82.70 M(-18.3%) |
| Mar 2014 | - | $101.25 M(-11.1%) |
| Dec 2013 | $113.89 M(+25.5%) | $113.89 M(-11.0%) |
| Sep 2013 | - | $128.03 M(+71.6%) |
| Jun 2013 | - | $74.59 M(-6.1%) |
| Mar 2013 | - | $79.43 M(-12.5%) |
| Dec 2012 | $90.78 M | $90.78 M(+101.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $44.99 M(+57.4%) |
| Jun 2012 | - | $28.57 M(+29.6%) |
| Mar 2012 | - | $22.04 M(+48.5%) |
| Dec 2011 | $14.85 M(+38.2%) | $14.85 M(+42.1%) |
| Sep 2011 | - | $10.45 M(+6.2%) |
| Jun 2011 | - | $9.84 M(-55.5%) |
| Mar 2011 | - | $22.10 M(+105.7%) |
| Dec 2010 | $10.74 M(-15.7%) | $10.74 M(-5.1%) |
| Jun 2010 | - | $11.32 M(-41.6%) |
| Mar 2010 | - | $19.36 M(+52.0%) |
| Dec 2009 | $12.74 M(+493.9%) | $12.74 M(-52.5%) |
| Sep 2009 | - | $26.84 M(+1151.2%) |
| Dec 2008 | $2.15 M(-87.0%) | $2.15 M(-62.8%) |
| Sep 2008 | - | $5.77 M(-38.9%) |
| Jun 2008 | - | $9.45 M(-21.5%) |
| Mar 2008 | - | $12.03 M(-27.0%) |
| Dec 2007 | $16.48 M(-31.7%) | $16.48 M(-12.9%) |
| Sep 2007 | - | $18.91 M(-15.0%) |
| Jun 2007 | - | $22.26 M(+84.9%) |
| Mar 2007 | - | $12.04 M(-50.1%) |
| Dec 2006 | $24.11 M(+28.0%) | $24.11 M(-31.1%) |
| Sep 2006 | - | $34.99 M(-27.6%) |
| Jun 2006 | - | $48.36 M(-18.3%) |
| Mar 2006 | - | $59.21 M(+214.3%) |
| Dec 2005 | $18.84 M(+104.2%) | $18.84 M(-8.9%) |
| Sep 2005 | - | $20.68 M(-27.3%) |
| Jun 2005 | - | $28.45 M(-20.5%) |
| Mar 2005 | - | $35.77 M(+287.9%) |
| Dec 2004 | $9.22 M(-68.8%) | $9.22 M(+22.8%) |
| Sep 2004 | - | $7.51 M(-46.6%) |
| Jun 2004 | - | $14.05 M(-43.6%) |
| Mar 2004 | - | $24.91 M(-15.6%) |
| Dec 2003 | $29.53 M(+8.0%) | $29.53 M(-8.3%) |
| Sep 2003 | - | $32.19 M(+46.3%) |
| Jun 2003 | - | $22.01 M(-12.4%) |
| Mar 2003 | - | $25.12 M(-8.1%) |
| Dec 2002 | $27.34 M(-46.7%) | $27.34 M(-12.3%) |
| Sep 2002 | - | $31.18 M(-14.0%) |
| Jun 2002 | - | $36.26 M(-14.4%) |
| Mar 2002 | - | $42.37 M(-17.3%) |
| Dec 2001 | $51.25 M(-28.4%) | $51.25 M(-10.6%) |
| Sep 2001 | - | $57.34 M(-14.2%) |
| Jun 2001 | - | $66.86 M(-7.3%) |
| Mar 2001 | - | $72.12 M(+0.7%) |
| Dec 2000 | $71.63 M(>+9900.0%) | $71.63 M(+143.8%) |
| Sep 2000 | - | $29.37 M(-16.4%) |
| Jun 2000 | - | $35.14 M(+1243.7%) |
| Mar 2000 | - | $2.62 M |
| Dec 1999 | $317.00 K | - |
FAQ
- What is Insmed Incorporated annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Insmed Incorporated?
- What is Insmed Incorporated annual cash & cash equivalents year-on-year change?
- What is Insmed Incorporated quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Insmed Incorporated?
- What is Insmed Incorporated quarterly cash and cash equivalents year-on-year change?
What is Insmed Incorporated annual cash & cash equivalents?
The current annual cash & cash equivalents of INSM is $482.37 M
What is the all time high annual cash & cash equivalents for Insmed Incorporated?
Insmed Incorporated all-time high annual cash & cash equivalents is $1.07 B
What is Insmed Incorporated annual cash & cash equivalents year-on-year change?
Over the past year, INSM annual cash & cash equivalents has changed by -$591.66 M (-55.09%)
What is Insmed Incorporated quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of INSM is $461.45 M
What is the all time high quarterly cash and cash equivalents for Insmed Incorporated?
Insmed Incorporated all-time high quarterly cash and cash equivalents is $1.25 B
What is Insmed Incorporated quarterly cash and cash equivalents year-on-year change?
Over the past year, INSM quarterly cash and cash equivalents has changed by -$25.66 M (-5.27%)